Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Comparative Analysis of Inflammatory Cytokine Release and Alveolar Epithelial Barrier Invasion in a Transwell® Bilayer Model of Mucormycosis.

Belic S, Page L, Lazariotou M, Waaga-Gasser AM, Dragan M, Springer J, Loeffler J, Morton CO, Einsele H, Ullmann AJ, Wurster S.

Front Microbiol. 2019 Jan 8;9:3204. doi: 10.3389/fmicb.2018.03204. eCollection 2018.

2.

Magnetic Binary Supersaturated Solid Solutions Processed by Severe Plastic Deformation.

Stückler M, Krenn H, Pippan R, Weissitsch L, Wurster S, Bachmaier A.

Nanomaterials (Basel). 2018 Dec 21;9(1). pii: E6. doi: 10.3390/nano9010006.

3.

Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Wurster S, Lewis RE, Albert ND, Kontoyiannis DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01896-18. doi: 10.1128/AAC.01896-18. Print 2019 Feb.

PMID:
30455245
4.

Evaluation of Aspergillus and Mucorales specific T-cells and peripheral blood mononuclear cell cytokine signatures as biomarkers of environmental mold exposure.

Page L, Weis P, Müller T, Dittrich M, Lazariotou M, Dragan M, Waaga-Gasser AM, Helm J, Dandekar T, Einsele H, Löffler J, Ullmann AJ, Wurster S.

Int J Med Microbiol. 2018 Dec;308(8):1018-1026. doi: 10.1016/j.ijmm.2018.09.002. Epub 2018 Sep 3.

PMID:
30201279
5.

Validation of a simplified in vitro Transwell® model of the alveolar surface to assess host immunity induced by different morphotypes of Aspergillus fumigatus.

Morton CO, Wurster S, Fliesser M, Ebel F, Page L, Hünniger K, Kurzai O, Schmitt AL, Michel D, Springer J, Einsele H, Loeffler J.

Int J Med Microbiol. 2018 Dec;308(8):1009-1017. doi: 10.1016/j.ijmm.2018.09.001. Epub 2018 Sep 3.

PMID:
30197238
6.

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.

PMID:
30150461
7.

Hyponatremia Induced by Duloxetine: A Case Report.

Hu D, Wurster S.

Consult Pharm. 2018 Aug 1;33(8):446-449. doi: 10.4140/TCP.n.2018.446.

PMID:
30068437
8.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Baumann R, Chan MKH, Pyschny F, Stera S, Malzkuhn B, Wurster S, Huttenlocher S, Szücs M, Imhoff D, Keller C, Balermpas P, Rades D, Rödel C, Dunst J, Hildebrandt G, Blanck O.

Front Oncol. 2018 May 17;8:171. doi: 10.3389/fonc.2018.00171. eCollection 2018.

9.

Treatment planning for spinal radiosurgery : A competitive multiplatform benchmark challenge.

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Strahlenther Onkol. 2018 Sep;194(9):843-854. doi: 10.1007/s00066-018-1314-2. Epub 2018 May 25.

PMID:
29802435
10.

Susceptibility of A. fumigatus-specific T-cell assays to pre-analytic blood storage and PBMC cryopreservation greatly depends on readout platform and analytes.

Lauruschkat CD, Wurster S, Page L, Lazariotou M, Dragan M, Weis P, Ullmann AJ, Einsele H, Löffler J.

Mycoses. 2018 Aug;61(8):549-560. doi: 10.1111/myc.12780. Epub 2018 Jun 11.

PMID:
29611226
11.

Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents.

Decker C, Wurster S, Lazariotou M, Hellmann AM, Einsele H, Ullmann AJ, Löffler J.

Med Mycol. 2018 Jun 1;56(4):514-519. doi: 10.1093/mmy/myx069.

PMID:
29420763
12.

Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.

Boda-Heggemann J, Jahnke A, Chan MKH, Ghaderi Ardekani LS, Hunold P, Schäfer JP, Huttenlocher S, Wurster S, Rades D, Hildebrandt G, Lohr F, Dunst J, Wenz F, Blanck O.

Strahlenther Onkol. 2018 May;194(5):414-424. doi: 10.1007/s00066-018-1271-9. Epub 2018 Feb 5.

PMID:
29404626
13.

Human and Murine Innate Immune Cell Populations Display Common and Distinct Response Patterns during Their In Vitro Interaction with the Pathogenic Mold Aspergillus fumigatus.

Hellmann AM, Lother J, Wurster S, Lutz MB, Schmitt AL, Morton CO, Eyrich M, Czakai K, Einsele H, Loeffler J.

Front Immunol. 2017 Dec 6;8:1716. doi: 10.3389/fimmu.2017.01716. eCollection 2017.

14.

Substrate-Influenced Thermo-Mechanical Fatigue of Copper Metallizations: Limits of Stoney's Equation.

Bigl S, Wurster S, Cordill MJ, Kiener D.

Materials (Basel). 2017 Nov 9;10(11). pii: E1287. doi: 10.3390/ma10111287.

15.

Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.

Stera S, Balermpas P, Chan MKH, Huttenlocher S, Wurster S, Keller C, Imhoff D, Rades D, Dunst J, Rödel C, Hildebrandt G, Blanck O.

Strahlenther Onkol. 2018 Feb;194(2):143-155. doi: 10.1007/s00066-017-1204-z. Epub 2017 Sep 5.

PMID:
28875297
16.

Intra- and inter-individual variability of Aspergillus fumigatus reactive T-cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment.

Wurster S, Weis P, Page L, Helm J, Lazariotou M, Einsele H, Ullmann AJ.

Mycoses. 2017 Oct;60(10):668-675. doi: 10.1111/myc.12643. Epub 2017 Aug 8.

PMID:
28786508
17.

Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins.

Wurster S, Thielen V, Weis P, Walther P, Elias J, Waaga-Gasser AM, Dragan M, Dandekar T, Einsele H, Löffler J, Ullmann AJ.

Virulence. 2017 Nov 17;8(8):1708-1718. doi: 10.1080/21505594.2017.1342920. Epub 2017 Aug 8.

18.

Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.

Chan M, Grehn M, Cremers F, Siebert FA, Wurster S, Huttenlocher S, Dunst J, Hildebrandt G, Schweikard A, Rades D, Ernst F, Blanck O.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):839-848. doi: 10.1016/j.ijrobp.2016.11.041. Epub 2016 Nov 27.

PMID:
28244421
19.

Quantification of A. fumigatus-specific CD154+ T-cells-preanalytic considerations.

Wurster S, Weis P, Page L, Lazariotou M, Einsele H, Ullmann AJ.

Med Mycol. 2017 Feb 1;55(2):223-227. doi: 10.1093/mmy/myw054. Epub 2016 Aug 2.

PMID:
27486216
20.

Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.

Andratschke N, Parys A, Stadtfeld S, Wurster S, Huttenlocher S, Imhoff D, Yildirim M, Rades D, Rödel CM, Dunst J, Hildebrandt G, Blanck O.

Radiat Oncol. 2016 May 28;11:74. doi: 10.1186/s13014-016-0652-4.

21.

Inverse treatment planning for spinal robotic radiosurgery: an international multi-institutional benchmark trial.

Blanck O, Wang L, Baus W, Grimm J, Lacornerie T, Nilsson J, Luchkovskyi S, Cano IP, Shou Z, Ayadi M, Treuer H, Viard R, Siebert FA, Chan MK, Hildebrandt G, Dunst J, Imhoff D, Wurster S, Wolff R, Romanelli P, Lartigau E, Semrau R, Soltys SG, Schweikard A.

J Appl Clin Med Phys. 2016 May 8;17(3):313-330. doi: 10.1120/jacmp.v17i3.6151.

22.

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response.

Wurster S, Hennes F, Parplys AC, Seelbach JI, Mansour WY, Zielinski A, Petersen C, Clauditz TS, Münscher A, Friedl AA, Borgmann K.

Oncotarget. 2016 Mar 1;7(9):9732-41. doi: 10.18632/oncotarget.6947.

23.
24.

β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.

Blankenburg R, Hackert K, Wurster S, Deenen R, Seidman JG, Seidman CE, Lohse MJ, Schmitt JP.

Circ Res. 2014 Jul 7;115(2):227-37. doi: 10.1161/CIRCRESAHA.115.303178. Epub 2014 May 14.

25.

Ammonia plasma treatment of polystyrene surfaces enhances proliferation of primary human mesenchymal stem cells and human endothelial cells.

Kleinhans C, Barz J, Wurster S, Willig M, Oehr C, Müller M, Walles H, Hirth T, Kluger PJ.

Biotechnol J. 2013 Mar;8(3):327-37. doi: 10.1002/biot.201200210. Epub 2012 Nov 9.

PMID:
23070995
26.

Loss of LIN9, a member of the DREAM complex, cooperates with SV40 large T antigen to induce genomic instability and anchorage-independent growth.

Hauser S, Ulrich T, Wurster S, Schmitt K, Reichert N, Gaubatz S.

Oncogene. 2012 Apr 5;31(14):1859-68. doi: 10.1038/onc.2011.364. Epub 2011 Aug 22.

PMID:
21860417
27.

Human kisspeptins activate neuropeptide FF2 receptor.

Lyubimov Y, Engstrom M, Wurster S, Savola JM, Korpi ER, Panula P.

Neuroscience. 2010 Sep 29;170(1):117-22. doi: 10.1016/j.neuroscience.2010.06.058. Epub 2010 Jul 1.

PMID:
20600636
28.

Lin9, a subunit of the mammalian DREAM complex, is essential for embryonic development, for survival of adult mice, and for tumor suppression.

Reichert N, Wurster S, Ulrich T, Schmitt K, Hauser S, Probst L, Götz R, Ceteci F, Moll R, Rapp U, Gaubatz S.

Mol Cell Biol. 2010 Jun;30(12):2896-908. doi: 10.1128/MCB.00028-10. Epub 2010 Apr 19.

29.

Selections that optimize RNA display in the yeast three-hybrid system.

Wurster SE, Maher LJ 3rd.

RNA. 2010 Feb;16(2):253-8. doi: 10.1261/rna.1880410. Epub 2009 Dec 14. Review.

30.

Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system.

Wurster SE, Bida JP, Her YF, Maher LJ 3rd.

Nucleic Acids Res. 2009 Oct;37(18):6214-24. doi: 10.1093/nar/gkp670. Epub 2009 Aug 20.

31.

Selection and characterization of anti-NF-kappaB p65 RNA aptamers.

Wurster SE, Maher LJ 3rd.

RNA. 2008 Jun;14(6):1037-47. doi: 10.1261/rna.878908. Epub 2008 Apr 21.

32.

Sequence-specific binding of DNA and RNA to immobilized Nickel ions.

Nastasijevic B, Becker NA, Wurster SE, Maher LJ 3rd.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):420-5. Epub 2007 Dec 7.

PMID:
18068116
33.

Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.

Sallinen J, Höglund I, Engström M, Lehtimäki J, Virtanen R, Sirviö J, Wurster S, Savola JM, Haapalinna A.

Br J Pharmacol. 2007 Feb;150(4):391-402. Epub 2007 Jan 15.

34.

Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections.

Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, Knobloch JK, Ragunath C, Kaplan JB, Mack D.

Biomaterials. 2007 Mar;28(9):1711-20. Epub 2006 Dec 21.

PMID:
17187854
35.

The proximate control of pupal color in swallowtail butterflies: implications for the evolution of environmentally cued pupal color in butterflies (Lepidoptera: Papilionidae).

Jones M, Rakes L, Yochum M, Dunn G, Wurster S, Kinney K, Hazel W.

J Insect Physiol. 2007 Jan;53(1):40-6. Epub 2006 Oct 10.

PMID:
17098249
36.

Structure-activity relationship of quinoline derivatives as potent and selective alpha(2C)-adrenoceptor antagonists.

Höglund IP, Silver S, Engström MT, Salo H, Tauber A, Kyyrönen HK, Saarenketo P, Hoffrén AM, Kokko K, Pohjanoksa K, Sallinen J, Savola JM, Wurster S, Kallatsa OA.

J Med Chem. 2006 Oct 19;49(21):6351-63.

PMID:
17034141
37.

Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents.

Helyes Z, Pintér E, Németh J, Sándor K, Elekes K, Szabó A, Pozsgai G, Keszthelyi D, Kereskai L, Engström M, Wurster S, Szolcsányi J.

Br J Pharmacol. 2006 Oct;149(4):405-15. Epub 2006 Sep 4.

38.

Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models.

Sándor K, Elekes K, Szabó A, Pintér E, Engström M, Wurster S, Szolcsányi J, Helyes Z.

Eur J Pharmacol. 2006 Jun 6;539(1-2):71-5. Epub 2006 Apr 18.

PMID:
16697366
39.
40.

Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors.

Ruuskanen JO, Laurila J, Xhaard H, Rantanen VV, Vuoriluoto K, Wurster S, Marjamäki A, Vainio M, Johnson MS, Scheinin M.

Br J Pharmacol. 2005 Jan;144(2):165-77.

41.

Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications.

Pattison MA, Wurster S, Webster TJ, Haberstroh KM.

Biomaterials. 2005 May;26(15):2491-500.

PMID:
15585251
42.

Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay.

Engström M, Närvänen A, Savola JM, Wurster S.

Peptides. 2004 Dec;25(12):2099-104.

PMID:
15572197
43.

Superagonism at the human somatostatin receptor subtype 4.

Engström M, Tomperi J, El-Darwish K, Ahman M, Savola JM, Wurster S.

J Pharmacol Exp Ther. 2005 Jan;312(1):332-8. Epub 2004 Aug 27.

PMID:
15333679
44.

Functional properties of Pfr(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors.

Engström M, Wurster S, Savola JM, Panula P.

Peptides. 2003 Dec;24(12):1947-54.

PMID:
15127947
45.

Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.

Peltonen JM, Nyrönen T, Wurster S, Pihlavisto M, Hoffrén AM, Marjamäki A, Xhaard H, Kanerva L, Savola JM, Johnson MS, Scheinin M.

Br J Pharmacol. 2003 Sep;140(2):347-58. Epub 2003 Aug 18.

46.
47.

Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

Savola JM, Hill M, Engstrom M, Merivuori H, Wurster S, McGuire SG, Fox SH, Crossman AR, Brotchie JM.

Mov Disord. 2003 Aug;18(8):872-83.

PMID:
12889076
48.

Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors.

Engström M, Brandt A, Wurster S, Savola JM, Panula P.

J Pharmacol Exp Ther. 2003 Jun;305(3):825-32. Epub 2003 Feb 20.

PMID:
12606605
49.

Interaction of folk medicinal plant extracts with human alpha2-adrenoceptor subtypes.

Saleem A, Engström M, Wurster S, Savola JM, Pihlaja K.

Z Naturforsch C. 2002 Mar-Apr;57(3-4):332-8.

PMID:
12064736
50.

Molecular mechanism for agonist-promoted alpha(2A)-adrenoceptor activation by norepinephrine and epinephrine.

Nyrönen T, Pihlavisto M, Peltonen JM, Hoffrén AM, Varis M, Salminen T, Wurster S, Marjamäki A, Kanerva L, Katainen E, Laaksonen L, Savola JM, Scheinin M, Johnson MS.

Mol Pharmacol. 2001 May;59(5):1343-54.

PMID:
11306720

Supplemental Content

Loading ...
Support Center